C. Ferri, M. Prince, and C. Brayne, Global prevalence of dementia: a Delphi consensus study, The Lancet, vol.366, issue.9503, pp.2112-2117, 2005.
DOI : 10.1016/S0140-6736(05)67889-0

A. Wimo, L. Jönsson, and A. Gustavsson, The economic impact of dementia in Europe in 2008-cost estimates from the Eurocode project, International Journal of Geriatric Psychiatry, vol.20, issue.(Suppl 1), pp.825-832, 2011.
DOI : 10.1002/gps.2610

M. , P. M. Albanese, and E. , For Kings' College London and London School of Economics. London: Alzheimer's Society, Gordon House, 2007.

R. Handels, C. Wolfs, and P. Aalten, Determinants of Care Costs of Patients With Dementia or Cognitive Impairment, Alzheimer Disease & Associated Disorders, vol.27, issue.1, pp.30-36, 2013.
DOI : 10.1097/WAD.0b013e318242da1d

J. Enfert, C. Lassale, and P. Prod-'homme, Attractivit?? de la France pour les essais cliniques : ??valuation par les laboratoires promoteurs, Th??rapie, vol.58, issue.3, pp.283-289, 2003.
DOI : 10.2515/therapie:2003045

C. Lassale, C. Sibenaler, and J. Béhier, La France, un pays attractif pour la recherche clinique internationale : enqu??te 2008 du Leem, Th??rapie, vol.63, issue.5, pp.345-357, 2008.
DOI : 10.2515/therapie:2008061

S. Courcier, C. Sibenaler, and M. Couderc, La France est un pays attractif pour la recherche clinique internationale : enqu??te 2006 du Leem, Th??rapie, vol.61, issue.5, pp.407-418, 2006.
DOI : 10.2515/therapie:2006070

S. 10-courcier-duplantier, P. Bouhours, and P. Pinton, Attractivit?? de la France pour la recherche clinique internationale : une ??tude du Leem dresse un constat peu favorable et sugg??re des voies d???am??lioration, Th??rapie, vol.59, issue.6, pp.629-638, 2004.
DOI : 10.2515/therapie:2004109

T. Harris and I. Carey, Optimising recruitment into a study of physical activity in older people: a randomised controlled trial of different approaches, Age and Ageing, vol.37, issue.6, pp.659-665, 2008.
DOI : 10.1093/ageing/afn159

G. Mainous, D. Smith, and M. Geesey, Factors Influencing Physician Referrals of Patients to Clinical Trials, Journal of the National Medical Association, vol.100, issue.11, pp.1298-1303, 2008.
DOI : 10.1016/S0027-9684(15)31508-X

A. Dev, T. Kauf, and A. Zekry, Factors influencing the participation of gastroenterologists and hepatologists in clinical research, BMC Health Services Research, vol.353, issue.1, p.208, 2008.
DOI : 10.1056/NEJMsb053723

J. Galvin, E. James, T. Meuser, L. Boise, and C. Connell, Predictors of Physician Referral for Patient Recruitment to Alzheimer Disease Clinical Trials, Alzheimer Disease & Associated Disorders, vol.23, issue.4, pp.352-356, 2009.
DOI : 10.1097/WAD.0b013e31819e0cac

J. Karlawish, M. Cary, J. Rubright, and T. Tenhave, How redesigning AD clinical trials might increase study partners' willingness to participate, Neurology, vol.71, issue.23, pp.1883-1888, 2008.
DOI : 10.1212/01.wnl.0000336652.05779.ea

A. Carr, R. Davis, and D. Spencer, Comparison of Recruitment Efforts Targeted at Primary Care Physicians Versus the Community at Large for Participation in Alzheimer Disease Clinical Trials, Alzheimer Disease & Associated Disorders, vol.24, issue.2, pp.165-170, 2010.
DOI : 10.1097/WAD.0b013e3181aba927

S. Andrieu, N. Coley, and V. Gardette, Representations and practices of prevention in elderly populations: Investigating acceptance to participate in and adhesion to an intervention study for the prevention of Alzheimer???s disease (accept study) ??? The need for a multidisciplinary approach, The journal of nutrition, health & aging, vol.14, issue.7, pp.352-354, 2012.
DOI : 10.1007/s12603-012-0045-9

I. Carrié, G. Van-kan, and S. Gillette-guyonnet, Recruitment strategies for preventive trials. The MAPT study (Multidomain Alzheimer Preventive Trial), The journal of nutrition, health & aging, vol.12, issue.12, pp.355-359, 2012.
DOI : 10.1007/s12603-012-0046-8

V. Diebolt and Y. Pletan, How to improve clinical research performances in France? Downloaded by: Harvard University 128.103, Thérapie, vol.63138, issue.10, pp.297-3002, 2008.